OPTIC
Phase 1 Completed
21 enrolled
Pembrolizumab With Locally Delivered Radiation Therapy for the Treatment of Metastatic Esophageal Cancers
Phase 1 Completed
16 enrolled 13 charts
ARC-12
Phase 1 Completed
94 enrolled
P102
Phase 1 Completed
151 enrolled
Clinical Trial of Metastasis Inhibitor NP-G2-044 in Patients With Advanced or Metastatic Treatment-Refractory Solid Tumor Malignancies
Phase 1 Completed
23 enrolled
A Study of CDX-585 in Patients With Advanced Malignancies
Phase 1 Completed
20 enrolled
A Clinical Study of CEA-targeted CAR-T in the Treatment of CEA-positive Advanced Malignant Solid Tumors
Phase 1 Completed
43 enrolled
Dose Escalation of RMC-5552 Monotherapy in Relapsed/Refractory Solid Tumors
Phase 1 Completed
58 enrolled
Tumor Antigen-sensitized DC Vaccine As an Adjuvant Therapy for Esophagus Cancer
Phase 1 Completed
25 enrolled
ACTolog
Phase 1 Completed
38 enrolled
A Dose Finding Study of ZW49 in Patients With HER2-Positive Cancers
Phase 1 Completed
112 enrolled
Dasatinib for the Prevention of Oxaliplatin-Induced Neuropathy in Patients With Metastatic Gastrointestinal Cancer Receiving FOLFOX Chemotherapy With or Without Bevacizumab
Phase 1 Completed
9 enrolled
Study to Assess Safety, Tolerability and Clinical Activity of BGB-290 in Combination With Temozolomide (TMZ) in Participants With Locally Advanced or Metastatic Solid Tumors
Phase 1 Completed
139 enrolled 36 charts
A First in Human, Dose Escalation Study of JAB-3068 (SHP2 Inhibitor) in Adult Patients With Advanced Solid Tumors
Phase 1 Completed
38 enrolled
Sym024 Monotherapy and in Combination With Sym021 in Patients With Advanced Solid Tumor Malignancies
Phase 1 Completed
48 enrolled
Safety, Tolerability and Pharmacokinetics of an Anti-PD-1 Monoclonal Antibody in Subjects With Advanced Malignancies
Phase 1 Completed
184 enrolled 20 charts
Phase I Dose Escalation Study for VIP152 in Patients With Advanced Cancer
Phase 1 Completed
110 enrolled
FAPrimo
Phase 1 Completed
18 enrolled
CHARIOT
Phase 1 Completed
36 enrolled 24 charts
Open-Label, Dose-Finding Study Evaluating Safety and PK of FPA144 in Patients With Advanced Solid Tumors
Phase 1 Completed
79 enrolled 21 charts
VICE
Phase 1 Completed
14 enrolled
EAGLE
Phase 1 Completed
15 enrolled
A Study of CDX-1140 (CD40) as Monotherapy or in Combination in Patients With Advanced Malignancies
Phase 1 Completed
132 enrolled
HAIC Combined Sintilimab for Liver Metastasis From Esophageal Squamous Cell Carcinoma
Phase 1 Completed
25 enrolled
M1231 in Participants With Solid Tumors
Phase 1 Completed
23 enrolled
A Study of the PD-L1xCD27 Bispecific Antibody CDX-527 in Patients With Advanced Malignancies
Phase 1 Completed
27 enrolled
A Study of PRT1419 in Patients With Advanced Solid Tumors
Phase 1 Completed
26 enrolled
Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of QBS10072S
Phase 1 Completed
15 enrolled
Endoscopic Assisted Calcium Electroporation in Esophageal Cancer
Phase 1 Completed
10 enrolled
A Phase 1 Study of Mixed Bacteria Vaccine (MBV) in Patients With Tumors Expressing NY-ESO-1 Antigen
Phase 1 Completed
17 enrolled 14 charts
NY-ESO-1 Plasmid DNA (pPJV7611) Cancer Vaccine
Phase 1 Completed
18 enrolled 12 charts
RAV12 in Treating Patients With Metastatic or Recurrent Adenocarcinoma
Phase 1 Completed
53 enrolled
177Lu-J591 Antibody in Patients With Nonprostate Metastatic Solid Tumors
Phase 1 Completed
20 enrolled
First-in-human Study of S-588210 (S-488210+S-488211)
Phase 1 Completed
10 enrolled
A Safety and Tolerability Study of INCAGN02390 in Select Advanced Malignancies
Phase 1 Completed
40 enrolled
Investigator Initiated Phase 1 Study of TBI-1201
Phase 1 Completed
18 enrolled
DOS
Phase 1 Completed
34 enrolled 13 charts
A Trial of ZD6474, Paclitaxel, Carboplatin, 5-Fluorouracil, and Radiation Therapy Followed by Surgery
Phase 1 Completed
9 enrolled 10 charts
Study of Safety & Efficacy of the Combination of LJM716 & BYL719 in Patients With Previously Treated Esophageal Squamous Cell Carcinoma (ESCC)
Phase 1 Completed
48 enrolled
PCA062 in pCAD-positive Tumors.
Phase 1 Completed
47 enrolled
A Phase I Study of BKM120 in Adult Chinese Patients With Advanced Solid Tumors
Phase 1 Completed
32 enrolled
A Safety and Tolerability Study of INCAGN02385 in Select Advanced Malignancies
Phase 1 Completed
22 enrolled
LDE225 + Everolimus in Advanced Gastroesophageal Adenocarcinoma
Phase 1 Completed
25 enrolled
Simultaneous Integrated Boost (SIB) in Esophageal Cancer
Phase 1 Completed
61 enrolled
Intrapleural BG00001 in Treating Patients With Malignant Pleural Mesothelioma or Malignant Pleural Effusions
Phase 1 Completed
Study of Pre-operative Combination Therapy With Mogamulizumab and Nivolumab Against Solid Cancer Patients
Phase 1 Completed
16 enrolled
To Evaluate the Efficacy of NY-ESO-1-specific T Cell Receptor Affinity Enhancing Specific T Cell in Solid Tumors
Phase 1 Completed
6 enrolled
SOX
Phase 1 Completed
40 enrolled
TGR-1202 Alone and in Combination With Either Nab-paclitaxel + Gemcitabine or With FOLFOX in Patients With Select Relapsed or Refractory Solid Tumors
Phase 1 Completed
66 enrolled
Ganetespib in Combination With Paclitaxel, Carboplatin, and Radiation Therapy in Treating Patients With Stage II-III Esophageal Cancer
Phase 1 Completed
3 enrolled